Samil Pharmaceutical Co.,Ltd (000520.KS)
KRW 13130.0
(-3.95%)
KRW 13130.0
(-3.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 196.34 Billion | 179.67 Billion | 134.24 Billion | 122.99 Billion | 121.1 Billion | 94.59 Billion |
| Cost of Revenue | 124.13 Billion | 112.19 Billion | 85.25 Billion | 73.96 Billion | 74.38 Billion | 59.8 Billion |
| Gross Profit | 72.21 Billion | 67.48 Billion | 48.98 Billion | 49.03 Billion | 46.72 Billion | 34.79 Billion |
| Operating Expenses | 65.75 Billion | 63.46 Billion | 48.58 Billion | 42.49 Billion | 41.9 Billion | 40.52 Billion |
| Selling, General and Administrative Expenses | 31.29 Billion | 29.17 Billion | 19.73 Billion | 16.09 Billion | 16.95 Billion | 18.88 Billion |
| Research and Development Expenses | 5.6 Billion | 2.9 Billion | 2.97 Billion | 3 Billion | 3.05 Billion | 2.18 Billion |
| Other Expenses | 30.69 Billion | 31.38 Billion | 25.88 Billion | 23.39 Billion | 21.88 Billion | 19.45 Billion |
| Cost and Expenses | 189.88 Billion | 175.65 Billion | 133.84 Billion | 116.46 Billion | 116.28 Billion | 100.33 Billion |
| Operating Income | 6.47 Billion | 4.01 Billion | 1.05 Billion | 6.53 Billion | 4.82 Billion | -5.73 Billion |
| Interest Expense | 3.54 Billion | 4.26 Billion | 6.2 Billion | 5.5 Billion | 3.9 Billion | 2.39 Billion |
| Income Tax Expense | -239.75 Million | 1.08 Billion | 585.3 Million | -142.5 Million | 669.34 Million | 427.61 Million |
| Earnings before Tax | 1.42 Billion | 1.05 Billion | -4.76 Billion | 1.19 Billion | 1.45 Billion | -8.13 Billion |
| Net Income | 1.66 Billion | -28.28 Million | -5.34 Billion | 1.34 Billion | 786.25 Million | -8.56 Billion |
| Earnings Per Share Basic | 116.16 | -2.03 | -386.63 | 99.70 | 58.55 | -736.85 |
| Earnings Per Share Diluted | 115.37 | -2.03 | -386.63 | 99.70 | 58.55 | -736.82 |
| Weighted Average Shares Outstanding | 14.32 Million | 13.91 Million | 13.82 Million | 13.44 Million | 13.42 Million | 11.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.41 Million | 13.91 Million | 13.82 Million | 13.44 Million | 13.42 Million | 11.62 Million |
| Gross Margin | 0.37 | 0.38 | 0.36 | 0.40 | 0.39 | 0.37 |
| EBIT Margin | 0.06 | 0.05 | 0.04 | 0.09 | 0.08 | -0.02 |
| Profit Margin | 0.01 | -0.00 | -0.04 | 0.01 | 0.01 | -0.09 |
| EBITDA | 11.82 Billion | 10.3 Billion | 5.11 Billion | 11.32 Billion | 8.81 Billion | -2.05 Billion |
| Earnings Before Tax Margin | 0.03 | 0.02 | 0.01 | 0.05 | 0.04 | -0.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 54.28 Billion | 54.29 Billion | 50.51 Billion | 196.34 Billion | 51.63 Billion | 48.46 Billion |
| Cost of Revenue | 33.66 Billion | 34.99 Billion | 31 Billion | 124.13 Billion | 33.72 Billion | 29.74 Billion |
| Gross Profit | 20.62 Billion | 19.3 Billion | 19.51 Billion | 72.21 Billion | 17.9 Billion | 18.71 Billion |
| Operating Expenses | 19.53 Billion | 17.23 Billion | 17.34 Billion | 65.75 Billion | -16.98 Billion | 16.91 Billion |
| Selling, General and Administrative Expenses | 17.94 Billion | 15.74 Billion | 15.92 Billion | - | 16.98 Billion | 7.9 Billion |
| Research and Development Expenses | 1.33 Billion | 1.38 Billion | 1.31 Billion | - | 1.6 Billion | 1.38 Billion |
| Other Expenses | -254.85 Million | -107.79 Million | -103.36 Million | -516.11 Million | -33.96 Billion | 74.42 Million |
| Cost and Expenses | 53.19 Billion | 52.22 Billion | 48.34 Billion | 189.88 Billion | 33.72 Billion | 46.65 Billion |
| Operating Income | 1.09 Billion | 2.07 Billion | 2.16 Billion | 6.46 Billion | 925.55 Million | 1.8 Billion |
| Interest Expense | 321.15 Million | 1.83 Billion | 155.85 Million | 3.54 Billion | 321.63 Million | 1.81 Billion |
| Income Tax Expense | 937.41 Million | 1.97 Billion | 586.08 Million | -239.75 Million | 530.18 Million | -2.32 Billion |
| Earnings before Tax | 1.28 Billion | 230.32 Million | 1.48 Billion | 1.42 Billion | -126.86 Million | -1.6 Billion |
| Net Income | 350.31 Million | -1.74 Billion | 894.11 Million | 1.66 Billion | -657.04 Million | 719.05 Million |
| Earnings Per Share Basic | 21.19 | -118.07 | 61.82 | - | -46.12 | 50.48 |
| Earnings Per Share Diluted | 21.19 | -118.07 | 61.82 | - | -46.12 | 35.40 |
| Weighted Average Shares Outstanding | 16.53 Million | 14.75 Million | 14.46 Million | 14.32 Million | 14.24 Million | 14.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.53 Million | 14.75 Million | 14.46 Million | 14.41 Million | 14.24 Million | 20.31 Million |
| Gross Margin | 0.38 | 0.36 | 0.39 | 0.37 | 0.35 | 0.39 |
| EBIT Margin | 0.05 | 0.06 | 0.07 | - | 0.35 | 0.07 |
| Profit Margin | 0.01 | -0.03 | 0.02 | 0.01 | -0.01 | 0.01 |
| EBITDA | 2.45 Billion | 3.43 Billion | 3.52 Billion | - | 17.9 Billion | 3.3 Billion |
| Earnings Before Tax Margin | 0.02 | 0.04 | 0.04 | 0.03 | 0.02 | 0.04 |
100090
LFST
AURUM
8104
VTNR
605069